Comments
IT major IBM has signed an agreement with Apollo Hospitals for deployment of the former’s Watson for Oncology and Watson for Genomics. The two cognitive computing platforms developed by IBM help in providing personalised and evidence-based cancer care. The two solutions will be deployed in 10 out of the 64 Apollo Hospitals in the country.
“Watson for Oncology will be available at the Apollo Chennai and Delhi hospitals, followed by Hyderabad, Mumbai, Kolkata, Ahmedabad, Bhubaneshwar and Madurai over the next few months,” Preetha Reddy, Vice-Chairperson, Apollo Hospitals Group, has said.
IBM Watson for Oncology, trained by Memorial Sloan Kettering (MSK), complements the work of oncologists by supporting them in clinical decision-making.
“The solution gives them access to evidence-based, personalised treatment options from more than 300 medical journals, over 200 textbooks, and nearly 15 million pages of text providing insight and comprehensive details on different treatment options, including key information on drug treatment selections,” an IBM statement has said.
The second solution, IBM Watson for Genomics, analyses massive bodies of genomic, clinical and pharmacological knowledge to help uncover potential therapeutic options to target genetic alterations in a patient’s tumour.
“Each person’s cancer journey is unique and hence each patient’s treatment plan must be unique too. IBM Watson for Oncology and Genomics will help the clinicians and oncologists at Apollo Hospitals augment their own expertise to deliver an unparalleled and personalised patient care across our hospitals,” she said.
“Using this genomic analysis, Watson produces a report for physicians, which identifies genetic alterations that are actionable based on literature as well as drugs and clinical trials that target those alterations,” the statement said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.